Capital Investment Advisory Services, LLC Gsk PLC Transaction History

Capital Investment Advisory Services, LLC

$988 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$42.05 - $47.77 $44,741 - $50,827	1,064 Added 21.16%	6,093 $265,000
Q1 2022 May 03, 2022	BUY	$40.23 - $47.74 $202,316 - $240,084	5,029 New	5,029 $219,000
Q3 2021 Oct 28, 2021	SELL	$38.79 - $43.16 $285,106 - $317,226	-7,350 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$36.52 - $41.46 $33,269 - $37,770	-911 Reduced 11.03%	7,350 $293,000
Q1 2021 May 05, 2021	BUY	$34.27 - $40.01 $40,609 - $47,411	1,185 Added 16.75%	8,261 $295,000
Q4 2020 Jan 25, 2021	SELL	$34.07 - $39.94 $12,333 - $14,458	-362 Reduced 4.87%	7,076 $260,000
Q3 2020 Oct 19, 2020	SELL	$38.11 - $42.99 $9,070 - $10,231	-238 Reduced 3.1%	7,438 $280,000
Q2 2020 Aug 05, 2020	SELL	$37.87 - $43.58 $59,115 - $68,028	-1,561 Reduced 16.9%	7,676 $313,000
Q1 2020 Apr 28, 2020	SELL	$32.47 - $48.83 $14,773 - $22,217	-455 Reduced 4.69%	9,237 $350,000
Q4 2019 Feb 04, 2020	BUY	$42.0 - $48.25 $82,194 - $94,425	1,957 Added 25.3%	9,692 $455,000
Q3 2019 Oct 17, 2019	SELL	$40.46 - $43.52 $52,031 - $55,966	-1,286 Reduced 14.26%	7,735 $330,000
Q2 2019 Aug 08, 2019	BUY	$39.4 - $42.7 $44,049 - $47,738	1,118 Added 14.15%	9,021 $371,000
Q1 2019 Apr 23, 2019	BUY	$38.57 - $42.69 $29,197 - $32,316	757 Added 10.59%	7,903 $330,000
Q4 2018 Feb 04, 2019	SELL	$37.8 - $42.69 $43,885 - $49,563	-1,161 Reduced 13.98%	7,146 $273,000
Q3 2018 Oct 30, 2018	BUY	$39.75 - $42.69 $45,195 - $48,538	1,137 Added 15.86%	8,307 $334,000
Q2 2018 Aug 01, 2018	SELL	$39.61 - $42.76 $5,268 - $5,687	-133 Reduced 1.82%	7,170 $289,000
Q1 2018 Apr 30, 2018	BUY	$36.18 - $40.15 $41,245 - $45,771	1,140 Added 18.5%	7,303 $285,000
Q4 2017 Jan 31, 2018	BUY	$35.34 - $41.9 $217,800 - $258,229	6,163	6,163 $219,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.

Account